George Demetri, Director at Blueprint Medicines Corp (BPMC), sold 10 shares at $58.56 ($586) on 2022-03-17, disclosed to the SEC on 2022-06-30.
Seasonal sale ($586) by Director — this insider has traded BPMC in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| BPMC | SELL | 2020-01-14 | $48K | — | Filing → |
| BPMC | SELL | 2020-01-09 | $275K | — | Filing → |
| BPMC | SELL | 2019-06-19 | $167K | — | Filing → |